Related Blog Posts
West LB raises his rating on BB Biotech
5 hours ago ago from Now Finance
Rating rising for Bb Biotech, the investment fund specializing in biotechnology companies. West LB Panmure in fact raised its recommendation from to given the defensive nature of its holdings in American companies. The title is currently suspended due to the excessive burden of U.S. participation has recommended a freeze on prices. Tags: American , invest Related posts Sales for BNP after bidding BancWest (0) Euro German superstar thanks ...
Related contentBiotechnology, Recombinant Proteins, Monoclonal Antibodies and Therapeutic Genes
18 hours ago ago from Software Gratis
Tamaño: 42.72 MB Formato: PDF Idioma: Inglés DOWNLOAD AQUI
Related contentLIX Detergent JSC estimates to gain 2009 profit of VND135 billion
15 hours ago ago from Vietnam Stock Market News
VNStockNews.com - Lam Van Kiet, chair of management board in LIX Detergent Joint Stock Co (LIXCO) announced that the company's market share has increased by 40 percent in the first nine months of 2009. In 2006-2008, the company's revenue growth rate was increasing by about 25 percent, while accumulative profit surged by 25.2 percent against that of 2007. In the first nine months of 2009, the company's progressive profit rose by 65 percent ...
Related contentGuaschetti: The forecasts are not rosy Negative Finance Reports
18 hours ago ago from Negative Finance Reports
Negative Finance Reports finance Home The New Market tries to return to the surface Guaschetti: The forecasts are not rosy Forecasts fibers by experts in the reopening of Wall Street. I think we can expect a crash of U.S. stock market today in this day of reopening, said Alexander Guaschetti, head of equity desk at Banca Profilo, For the next few days ...
Related contentCramer on BloggingStocks: Buy Citi on the deal
3 hours ago ago from BloggingStocks
From TheStreet.com Network Should Citigroup Rush to Repay TARP? Citigroup Reportedly Prepping Equity Raise TheStreet.com's Jim Cramer says this one'll make you a bundle by 2012. Buy Citigroup ( C ) ( Cramer's Take ). No, not in the open market, but on the deal or deals, depending upon how heavy-handed the government's going to be. I initially recommended this stock in the low $3s and saw it go to $5, where I begged the government ...
Related contentRelated News
Glaxo plans to beat rivals in emerging markets
4 hours ago ago from PopEater
LONDON -GlaxoSmithKline PLC said Thursday it plans to outpace its rivals in the race to emerging markets as revenue from traditional western pharmaceutical markets continues to slow. Abbas Hussein, London-based Glaxo's head of emerging markets, said that the company will pursue acquisitions and alliances in the region, although he cautioned that targets are scarce and prices being demanded by some businesses are unreasonable. Hussein said ...
Related contentMagForce Nanotechnologies AG appoints Dr. Peter Heinrich as Chief Executive Officer
5 hours ago ago from PopEater
MagForce Nanotechnologies AG (FWB:MF6) has announced the appointment of Dr. Peter Heinrich, until now the deputy chairman of its supervisory board, as the company’s new chief executive officer effective January 1, 2010. The appointment follows the decision of Dr. Uwe Maschek to resign at his own request as CEO as of December 31, 2009. Dr. Peter Heinrich was co-founder of MediGene AG and served as its managing director and CEO from 1995 until ...
Related contentS&P raises market cap levels for major indices
18 hours ago ago from U.S. News
S&P raises market cap levels for major indices NEW YORK (AP) -- Ratings service Standard & Poor's on Wednesday set new market capitalization levels companies must meet in order to be listed on its U.S. indices. To be listed on the S&P 500, a company's total market capitalization - the total dollar value of outstanding shares - must be $3.5 billion or greater. Companies with market caps of $850 million to $3.8 billion may be listed on the ...
Related contentRelated Videos
Nothing to see... move along.
